Evidence map›Paper›PMID 24359314›Full record

ArticleBiochemistry2014

Diverse levels of sequence selectivity and catalytic efficiency of protein-tyrosine phosphatases.

Nicholas G Selner, Rinrada Luechapanichkul, Xianwen Chen, Benjamin G Neel, Zhong-Yin Zhang, Stefan Knapp, Charles E Bell, Dehua Pei

Abstract read
In one paragraph

Article in Biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Review
  3. Multipartite Fluorogenic Sensors for Monitoring Tyrosine Phosphatase Activity.Chembiochem : a European journal of chemical biology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Interrogating Protein Phosphatases with Chemical Activity Probes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2018
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Nicholas G SelnerDepartment of Chemistry and Biochemistry, The Ohio State University , 484 West 12th Avenue, Columbus, Ohio 43210, United States.
Rinrada Luechapanichkul
Xianwen Chen
Benjamin G Neel
Zhong-Yin Zhang
Stefan Knapp
Charles E Bell
Dehua Pei
The Ohio State University · USIndiana University – Purdue University Indianapolis · USPrincess Margaret Cancer Centre · CAUniversity of Oxford · GB

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Structure/Function of Protein Tyrosine PhosphatasesR01CA069202 · NCI · YESHIVA UNIVERSITY · PI Zhong-Yin Zhang · 1996 to 2026
$7.3M
Recognition and Catalysis of Phosphotyrosyl ProteinsR01GM062820 · NIGMS · OHIO STATE UNIVERSITY · PI PEI, DEHUA · 2003 to 2015
$3.2M
Substrate Profiling of Protein Tyrosine PhosphatasesR01CA132855 · NCI · OHIO STATE UNIVERSITY · PI PEI, DEHUA · 2009 to 2013
$1.3M
CIHRNCI NIH HHS CA132855NCI NIH HHS CA69202NCI NIH HHS P30 CA016058NCI NIH HHS R01 CA069202NCI NIH HHS R01 CA132855NIGMS NIH HHS GM062820NIGMS NIH HHS R01 GM062820Wellcome Trust 092809Wellcome Trust 092809/Z/10/Z
6 · The paper itself

Abstract

The sequence selectivity of 14 classical protein-tyrosine phosphatases (PTPs) (PTPRA, PTPRB, PTPRC, PTPRD, PTPRO, PTP1B, SHP-1, SHP-2, HePTP, PTP-PEST, TCPTP, PTPH1, PTPD1, and PTPD2) was systematically profiled by screening their catalytic domains against combinatorial peptide libraries. All of the PTPs exhibit similar preference for pY peptides rich in acidic amino acids and disfavor positively charged sequences but differ vastly in their degrees of preference/disfavor. Some PTPs (PTP-PEST, SHP-1, and SHP-2) are highly selective for acidic over basic (or neutral) peptides (by >10(5)-fold), whereas others (PTPRA and PTPRD) show no to little sequence selectivity. PTPs also have diverse intrinsic catalytic efficiencies (kcat/KM values against optimal substrates), which differ by >10(5)-fold due to different kcat and/or KM values. Moreover, PTPs show little positional preference for the acidic residues relative to the pY residue. Mutation of Arg47 of PTP1B, which is located near the pY-1 and pY-2 residues of a bound substrate, decreased the enzymatic activity by 3-18-fold toward all pY substrates containing acidic residues anywhere within the pY-6 to pY+5 region. Similarly, mutation of Arg24, which is situated near the C-terminus of a bound substrate, adversely affected the kinetic activity of all acidic substrates. A cocrystal structure of PTP1B bound with a nephrin pY(1193) peptide suggests that Arg24 engages in electrostatic interactions with acidic residues at the pY+1, pY+2, and likely other positions. These results suggest that long-range electrostatic interactions between positively charged residues near the PTP active site and acidic residues on pY substrates allow a PTP to bind acidic substrates with similar affinities, and the varying levels of preference for acidic sequences by different PTPs are likely caused by the different electrostatic potentials near their active sites. The implications of the varying sequence selectivity and intrinsic catalytic activities with respect to PTP in vivo substrate specificity and biological functions are discussed.

Indexed as

BiocatalysisCatalytic DomainCrystallography, X-RayKineticsModels, MolecularPeptide LibraryPeptidesProtein Tyrosine PhosphatasesStatic ElectricityStreptomyces antibioticusSubstrate SpecificityPeptide LibraryPeptidesProtein Tyrosine Phosphatases

Identifiers

PMID24359314
PMCPMC3954597
OpenAlexW2277722811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.